JCI Colloidal Iodine Laboratory

JCI Colloidal Iodine Laboratory is a Japan-based healthcare product developer and manufacturer focused on proprietary colloidal iodine formulations marketed under the JCI MN Colloidal Iodine brand. The company promotes oral, injectable, inhaled, ophthalmic, and topical iodine-based products for a wide range of conditions, with a particular emphasis on cancer and other difficult-to-treat diseases. Its website states that its colloidal iodine products are used in Japan and abroad, and that its product was approved by Sri Lanka's Ministry of Ayurveda in 2016, while also noting that the product is unapproved in Japan. In the United States, at least some products appear in FDA labeling systems as human OTC drug listings, but DailyMed indicates they are "unapproved drug other" and have not been found by FDA to be safe and effective. Overall, this appears to be a niche alternative/integrative medicine-oriented healthcare company rather than a conventional clinical-stage biotech with a disclosed modern drug pipeline.